(Q34539241)

2 August 2017

1 reference

title

Non-surgical treatment of hepatocellular carcinoma. (English)

1 reference

2 August 2017

Alsowmely AM

1

1 reference

PubMed ID

11856073

2 August 2017

Hodgson HJ

series ordinal

2

1 reference

PubMed ID

11856073

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Alimentary Pharmacology & Therapeutics

2 August 2017

1 reference

2 August 2017

16

1 reference

2 August 2017

1

1 reference

2 August 2017

1-15

1 reference

Radiofrequency ablation in the treatment of hepatocellular carcinoma--a clinical viewpoint.

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Treatment of small hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Liver transplantation: current status and novel approaches to liver replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Nonresectional therapies for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Local ablation therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Treatment of hepatocellular carcinoma: too many options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Needle tract recurrence of hepatocellular carcinoma after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Percutaneous ethanol injection of the supplying artery to hepatocellular carcinoma that is not amenable to conventional treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

New applications of ultrasonography: interventional ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Interstitial laser hyperthermia: a new approach to local destruction of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Etiology, screening, and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Primary treatment of hepatocellular carcinoma by arterial chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Current treatment modalities for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

The effect of retreatment with interferon-alpha on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Octreotide for cancer of the liver and biliary tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

90Yttrium antiferritin--a new therapeutic radiolabeled antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Treatment for unresectable hepatoma via selective hepatic arterial infusion of lymphokine-activated killer cells generated from autologous spleen cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

The potential of gene therapy in the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Early diagnosis and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Locoregional treatments for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection,

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Prospective Validation of the Cancer of the Liver Italian Program(CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01149.X

10.1046/J.1365-2036.2002.01149.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11856073